237 related articles for article (PubMed ID: 18354070)
21. [A case of Usher's syndrome associated with psychotic symptoms: diagnosis and follow-up in a psychiatric unit].
Viala A; Nicot T; Levy F; Vacheron MN
Encephale; 2009 Jun; 35(3):286-91. PubMed ID: 19540416
[TBL] [Abstract][Full Text] [Related]
22. Using aripiprazole to treat new-onset hyperprolactinemia-related delusion of pregnancy.
Hu LY; Lee YT; Lu T; Hung MB; Hung YY
Aust N Z J Psychiatry; 2015 Oct; 49(10):946. PubMed ID: 26101399
[No Abstract] [Full Text] [Related]
23. Sex differences in prolactin levels in emerging psychosis: Indication for enhanced stress reactivity in women.
Ittig S; Studerus E; Heitz U; Menghini-Müller S; Beck K; Egloff L; Leanza L; Andreou C; Riecher-Rössler A
Schizophr Res; 2017 Nov; 189():111-116. PubMed ID: 28214176
[TBL] [Abstract][Full Text] [Related]
24. Categorical prevalence and severity of hyperprolactinaemia in two UK cohorts of patients with severe mental illness during treatment with antipsychotics.
Bushe C; Yeomans D; Floyd T; Smith SM
J Psychopharmacol; 2008 Mar; 22(2 Suppl):56-62. PubMed ID: 18477621
[TBL] [Abstract][Full Text] [Related]
25. Hyperprolactinemia - side effect or part of the illness.
Vuk Pisk S; Matić K; Gereš N; Ivezić E; Ruljančić N; Filipčić I
Psychiatr Danub; 2019 Jun; 31(Suppl 2):148-152. PubMed ID: 31158115
[TBL] [Abstract][Full Text] [Related]
26. Hyperprolactinemia in patients on antipsychotic drugs causes ADP-stimulated platelet activation that might explain the increased risk for venous thromboembolism: pilot study.
Wallaschofski H; Eigenthaler M; Kiefer M; Donné M; Hentschel B; Gertz HJ; Lohmann T
J Clin Psychopharmacol; 2003 Oct; 23(5):479-83. PubMed ID: 14520125
[TBL] [Abstract][Full Text] [Related]
27. [Hyperprolactinemia induced by antipsychotic agents].
Johnsen E; Jørgensen HA
Tidsskr Nor Laegeforen; 2006 Jan; 126(2):179-80. PubMed ID: 16415943
[No Abstract] [Full Text] [Related]
28. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
29. [Impact of neuroleptic-induced hyperprolactinemia on sexual dysfunction in male schizophrenic patients].
Konarzewska B; Szulc A; Popławska R; Galińska B; Juchnowicz D
Psychiatr Pol; 2008; 42(1):87-95. PubMed ID: 18567406
[TBL] [Abstract][Full Text] [Related]
30. Antipsychotics and hyperprolactinaemia: mechanisms, consequences and management.
Holt RI; Peveler RC
Clin Endocrinol (Oxf); 2011 Feb; 74(2):141-7. PubMed ID: 20455888
[TBL] [Abstract][Full Text] [Related]
31. A case of venous thromboembolism probably associated with hyperprolactinemia after the addition of olanzapine to typical antipsychotics.
Toki S; Morinobu S; Yoshino A; Yamawaki S
J Clin Psychiatry; 2004 Nov; 65(11):1576-7. PubMed ID: 15554776
[No Abstract] [Full Text] [Related]
32. Hyperprolactinemia-related adverse events associated with antipsychotic treatment in children and adolescents.
Jerrell JM; Bacon J; Burgis JT; Menon S
J Adolesc Health; 2009 Jul; 45(1):70-6. PubMed ID: 19541252
[TBL] [Abstract][Full Text] [Related]
33. A randomized, crossover comparison of herbal medicine and bromocriptine against risperidone-induced hyperprolactinemia in patients with schizophrenia.
Yuan HN; Wang CY; Sze CW; Tong Y; Tan QR; Feng XJ; Liu RM; Zhang JZ; Zhang YB; Zhang ZJ
J Clin Psychopharmacol; 2008 Jun; 28(3):264-370. PubMed ID: 18480682
[TBL] [Abstract][Full Text] [Related]
34. Psychotropic-induced hyperprolactinemia: a clinical review.
Ajmal A; Joffe H; Nachtigall LB
Psychosomatics; 2014; 55(1):29-36. PubMed ID: 24140188
[TBL] [Abstract][Full Text] [Related]
35. Antipsychotic drug-induced hyperprolactinemia: clinical implications.
Molitch ME
Endocr Pract; 2000; 6(6):479-81. PubMed ID: 11155224
[No Abstract] [Full Text] [Related]
36. A review of the association between antipsychotic use and hyperprolactinaemia.
Bushe C; Shaw M; Peveler RC
J Psychopharmacol; 2008 Mar; 22(2 Suppl):46-55. PubMed ID: 18477620
[TBL] [Abstract][Full Text] [Related]
37. Recent clinical aspects of hyperprolactinemia induced by antipsychotics.
Milano W; D'Acunto CW; De Rosa M; Festa M; Milano L; Petrella C; Capasso A
Rev Recent Clin Trials; 2011 Jan; 6(1):52-63. PubMed ID: 20868350
[TBL] [Abstract][Full Text] [Related]
38. [The assessment of the mental state of patients during simultaneous treatment with psychotropic drugs, antipsychotics included, and bromocriptine].
Barszcz Z; Mucha S; Rabe-Jabłońska J
Psychiatr Pol; 2008; 42(4):595-607. PubMed ID: 19189603
[TBL] [Abstract][Full Text] [Related]
39. [Post-partum delusion of pregnancy: an integrated view].
Simon M; Vörös V; Herold R; Fekete S; Tényi T
Neuropsychopharmacol Hung; 2009 Jun; 11(2):103-10. PubMed ID: 19827318
[TBL] [Abstract][Full Text] [Related]
40. Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia.
O'Keane V
J Psychopharmacol; 2008 Mar; 22(2 Suppl):70-5. PubMed ID: 18477623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
